Department of Nephrology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.
Clin J Am Soc Nephrol. 2012 May;7(5):765-74. doi: 10.2215/CJN.08850811. Epub 2012 Mar 8.
Sudden death is common in hemodialysis patients, but whether modifiable practices affect the risk of sudden death remains unclear.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study analyzed 37,765 participants in 12 countries in the Dialysis Outcomes and Practice Patterns Study to explore the association of the following practices with sudden death (due to cardiac arrhythmia, cardiac arrest, and/or hyperkalemia): treatment time [TT] <210 minutes, Kt/V <1.2, ultrafiltration volume >5.7% of postdialysis weight, low dialysate potassium [K(D) <3]), and prescription of Q wave/T wave interval-prolonging drugs. Cox regression was used to estimate effects on mortality, adjusting for potential confounders. An instrumental variable approach was used to further control for unmeasured patient-level confounding.
There were 9046 deaths, 26% of which were sudden (crude mortality rate, 15.3/100 patient-years; median follow-up, 1.59 years). Associations with sudden death included hazard ratios of 1.13 for short TT, 1.15 for large ultrafiltration volume, and 1.10 for low Kt/V. Compared with K(D) ≥3 mEq/L, the sudden death rate was higher for K(D) ≤1.5 and K(D)=2-2.5 mEq/L. The instrumental variable approach yielded generally consistent findings. The sudden death rate was elevated for patients taking amiodarone, but not other Q wave/T wave interval-prolonging drugs.
This study identified modifiable dialysis practices associated with higher risk of sudden death, including short TT, large ultrafiltration volume, and low K(D). Because K(D) <3 mEq/L is common and easy to change, K(D) tailoring may prevent some sudden deaths. This hypothesis merits testing in clinical trials.
在血液透析患者中,猝死较为常见,但可改变的做法是否会影响猝死风险尚不清楚。
设计、地点、参与者和测量:本研究分析了来自 12 个国家的 37765 名参与者的 Dialysis Outcomes and Practice Patterns Study 数据,以探讨以下做法与猝死(由心律失常、心脏骤停和/或高钾血症引起)之间的关联:治疗时间(TT)<210 分钟,Kt/V <1.2,超滤量>透析后体重的 5.7%,透析液钾浓度低[K(D) <3],以及开处方使用 Q 波/T 波间期延长药物。使用 Cox 回归来估计对死亡率的影响,调整潜在混杂因素。使用工具变量法进一步控制未测量的患者水平混杂因素。
共有 9046 人死亡,其中 26%为猝死(粗死亡率为 15.3/100 患者年;中位随访时间为 1.59 年)。与猝死相关的危险比包括 TT 较短为 1.13,超滤量较大为 1.15,Kt/V 较低为 1.10。与 K(D)≥3 mEq/L 相比,K(D)≤1.5 mEq/L 和 K(D)=2-2.5 mEq/L 的猝死率更高。工具变量法得出的结果大致一致。服用胺碘酮的患者猝死率升高,但服用其他 Q 波/T 波间期延长药物的患者猝死率没有升高。
本研究确定了与较高猝死风险相关的可改变的透析做法,包括 TT 较短、超滤量较大和 K(D)较低。由于 K(D) <3 mEq/L 很常见且易于改变,因此调整 K(D)可能会预防一些猝死。这一假设值得在临床试验中进行检验。